OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

22K COLL shares were withheld to cover taxes or exercise cost (Officer) | OQRO

Home
Insider trades
Collegium Pharmaceutical, Inc.
22K COLL shares were withheld to cover taxes or exercise cost (Officer

Insider trades

Insider trade

22K COLL shares were withheld to cover taxes or exercise cost (Officer)

Traded Feb 10, 2026 · Filed Feb 12, 2026

COLCollegium Pharmaceutical, Inc.COLL

22K
Shares · @ $46.75

Why it stands out

Routine share withholding; mechanical by default.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 10, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 12, 2026

OfficerTax withholding

Context

Classification

tax withholding

Code F — shares delivered to pay exercise price or tax liability

Planned / mechanical clue

Tax mechanics (code F)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001746251-26-000002

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Feb 12, 2026, 9:30 PM UTC

Added to OQRO

Oct 6, 2026, 10:35 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

COLLEGIUM PHARMACEUTICAL, INC

Issuer CIK

1267565

Ticker

COLL

Reporting person

Scott Dreyer

Relationship

Officer

Officer title

EVP & Chief Commercial Officer

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Feb 10, 2026

Transaction code

Shares / units

21,615

Price per share

$46.75

Acquired / disposed

Disposed (D)

Shares owned after

121,746

Ownership form

Direct

Amendment

Footnotes from the filing

Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.

Around the same time

David Dieter (EVP & General Counsel) sold ~$228K of Collegium Pharmaceutical, Inc.

Scheduled in advanceFiled 7mo ago

Scott Dreyer (EVP & Chief Commercial Officer) sold ~$1.87M of Collegium Pharmaceutical, Inc.

Scheduled in advanceFiled 7mo ago

Scott Dreyer (EVP & Chief Commercial Officer) sold ~$146K of Collegium Pharmaceutical, Inc.

Scheduled in advanceFiled 7mo ago